Spinal and Bulbar Muscular Atrophy clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients
open to eligible males ages 18 years and up
This is a phase 1/2a randomized, double-blind study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of study drug AJ201 in subjects with Spinal and Bulbar Muscular Atrophy (SBMA).
Orange, California and other locations